Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.18% |
| Dec 31, 2025 | -9.12% |
| Sep 30, 2025 | -53.98% |
| Jun 30, 2025 | 373.02% |
| Mar 31, 2025 | -19.09% |
| Dec 31, 2024 | 24.85% |
| Sep 30, 2024 | 2,997.20% |
| Jun 30, 2024 | 105.93% |
| Mar 31, 2024 | -460.56% |
| Dec 31, 2023 | 143.85% |
| Sep 30, 2023 | 16.88% |
| Jun 30, 2023 | 73.24% |
| Mar 31, 2023 | -662.76% |
| Dec 31, 2022 | 108.43% |
| Sep 30, 2022 | 2.22% |
| Jun 30, 2022 | -4.55% |
| Mar 31, 2022 | -32.18% |
| Dec 31, 2021 | -9.75% |
| Sep 30, 2021 | -102.52% |
| Jun 30, 2021 | -108.62% |
| Mar 31, 2021 | 296.17% |
| Dec 31, 2020 | -36.62% |
| Sep 30, 2020 | 34.80% |
| Jun 30, 2020 | -133.27% |
| Mar 31, 2020 | 379.29% |
| Dec 31, 2019 | 96.48% |
| Dec 31, 2011 | -91.49% |
| Sep 30, 2011 | -46.46% |
| Jun 30, 2011 | -62.39% |
| Mar 31, 2011 | -102.47% |
| Dec 31, 2010 | -127.90% |
| Sep 30, 2010 | 211.11% |